An integrated microfluidic chip for one-step isolation of circulating tumor cells

Tae Yoon Lee, Kyung A. Hyun, Seung Il Kim, Hyo il Jung

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

The presence of circulating tumor cells (CTCs) in blood of cancer patients is thought to be an important indicator of disease progression and survival. Due to the rarity of CTCs in the bloodstream, CTCs must be enriched for molecular and cellular analyses for clinical use. Current CTC detection methods mostly rely on epithelial cell adhesion molecule (EpCAM); however, these methods may underestimate CTC number and potentially miss a critical subpopulation because of large heterogeneity among CTCs. We describe an integrated microfluidic chip, termed the μ-MixMACS chip, that can negatively exclude background cells from a CTC population. It comprises a micromixer that generates multivortexing flows to enhance mixing, which increasing binding between white blood cells and magnetic nanoparticles coated CD45 antibody, and a magnetic sorter to remove magnet-coated cells and minimize interference from white blood cells during subsequent CTC analysis. As all processes were carried out continuous manner, any CTC loss during isolation was minimized. Blood samples from 10 patients with adjuvant breast cancer were analyzed. CTCs were sorted as unfixed cells in solution. CTCs were isolated from 5 of 10 blood samples, 1–3 CTCs were found in each of these 5 samples. The proposed μ-MixMACS chip is expected to be useful for isolating CTCs from a variety of tumor types without any changes.

Original languageEnglish
Pages (from-to)1144-1150
Number of pages7
JournalSensors and Actuators, B: Chemical
Volume238
DOIs
Publication statusPublished - 2017 Jan 1

Fingerprint

Microfluidics
Tumors
isolation
tumors
chips
Cells
Blood
cells
blood
leukocytes
cancer
Cell adhesion
Cell Adhesion Molecules
antibodies
Antibodies
progressions
breast
Magnets
adhesion
magnets

All Science Journal Classification (ASJC) codes

  • Electronic, Optical and Magnetic Materials
  • Instrumentation
  • Condensed Matter Physics
  • Surfaces, Coatings and Films
  • Metals and Alloys
  • Electrical and Electronic Engineering
  • Materials Chemistry

Cite this

Lee, Tae Yoon ; Hyun, Kyung A. ; Kim, Seung Il ; Jung, Hyo il. / An integrated microfluidic chip for one-step isolation of circulating tumor cells. In: Sensors and Actuators, B: Chemical. 2017 ; Vol. 238. pp. 1144-1150.
@article{5a5c7d9fe5424b048717eb89c39e35d7,
title = "An integrated microfluidic chip for one-step isolation of circulating tumor cells",
abstract = "The presence of circulating tumor cells (CTCs) in blood of cancer patients is thought to be an important indicator of disease progression and survival. Due to the rarity of CTCs in the bloodstream, CTCs must be enriched for molecular and cellular analyses for clinical use. Current CTC detection methods mostly rely on epithelial cell adhesion molecule (EpCAM); however, these methods may underestimate CTC number and potentially miss a critical subpopulation because of large heterogeneity among CTCs. We describe an integrated microfluidic chip, termed the μ-MixMACS chip, that can negatively exclude background cells from a CTC population. It comprises a micromixer that generates multivortexing flows to enhance mixing, which increasing binding between white blood cells and magnetic nanoparticles coated CD45 antibody, and a magnetic sorter to remove magnet-coated cells and minimize interference from white blood cells during subsequent CTC analysis. As all processes were carried out continuous manner, any CTC loss during isolation was minimized. Blood samples from 10 patients with adjuvant breast cancer were analyzed. CTCs were sorted as unfixed cells in solution. CTCs were isolated from 5 of 10 blood samples, 1–3 CTCs were found in each of these 5 samples. The proposed μ-MixMACS chip is expected to be useful for isolating CTCs from a variety of tumor types without any changes.",
author = "Lee, {Tae Yoon} and Hyun, {Kyung A.} and Kim, {Seung Il} and Jung, {Hyo il}",
year = "2017",
month = "1",
day = "1",
doi = "10.1016/j.snb.2016.05.163",
language = "English",
volume = "238",
pages = "1144--1150",
journal = "Sensors and Actuators, B: Chemical",
issn = "0925-4005",
publisher = "Elsevier",

}

An integrated microfluidic chip for one-step isolation of circulating tumor cells. / Lee, Tae Yoon; Hyun, Kyung A.; Kim, Seung Il; Jung, Hyo il.

In: Sensors and Actuators, B: Chemical, Vol. 238, 01.01.2017, p. 1144-1150.

Research output: Contribution to journalArticle

TY - JOUR

T1 - An integrated microfluidic chip for one-step isolation of circulating tumor cells

AU - Lee, Tae Yoon

AU - Hyun, Kyung A.

AU - Kim, Seung Il

AU - Jung, Hyo il

PY - 2017/1/1

Y1 - 2017/1/1

N2 - The presence of circulating tumor cells (CTCs) in blood of cancer patients is thought to be an important indicator of disease progression and survival. Due to the rarity of CTCs in the bloodstream, CTCs must be enriched for molecular and cellular analyses for clinical use. Current CTC detection methods mostly rely on epithelial cell adhesion molecule (EpCAM); however, these methods may underestimate CTC number and potentially miss a critical subpopulation because of large heterogeneity among CTCs. We describe an integrated microfluidic chip, termed the μ-MixMACS chip, that can negatively exclude background cells from a CTC population. It comprises a micromixer that generates multivortexing flows to enhance mixing, which increasing binding between white blood cells and magnetic nanoparticles coated CD45 antibody, and a magnetic sorter to remove magnet-coated cells and minimize interference from white blood cells during subsequent CTC analysis. As all processes were carried out continuous manner, any CTC loss during isolation was minimized. Blood samples from 10 patients with adjuvant breast cancer were analyzed. CTCs were sorted as unfixed cells in solution. CTCs were isolated from 5 of 10 blood samples, 1–3 CTCs were found in each of these 5 samples. The proposed μ-MixMACS chip is expected to be useful for isolating CTCs from a variety of tumor types without any changes.

AB - The presence of circulating tumor cells (CTCs) in blood of cancer patients is thought to be an important indicator of disease progression and survival. Due to the rarity of CTCs in the bloodstream, CTCs must be enriched for molecular and cellular analyses for clinical use. Current CTC detection methods mostly rely on epithelial cell adhesion molecule (EpCAM); however, these methods may underestimate CTC number and potentially miss a critical subpopulation because of large heterogeneity among CTCs. We describe an integrated microfluidic chip, termed the μ-MixMACS chip, that can negatively exclude background cells from a CTC population. It comprises a micromixer that generates multivortexing flows to enhance mixing, which increasing binding between white blood cells and magnetic nanoparticles coated CD45 antibody, and a magnetic sorter to remove magnet-coated cells and minimize interference from white blood cells during subsequent CTC analysis. As all processes were carried out continuous manner, any CTC loss during isolation was minimized. Blood samples from 10 patients with adjuvant breast cancer were analyzed. CTCs were sorted as unfixed cells in solution. CTCs were isolated from 5 of 10 blood samples, 1–3 CTCs were found in each of these 5 samples. The proposed μ-MixMACS chip is expected to be useful for isolating CTCs from a variety of tumor types without any changes.

UR - http://www.scopus.com/inward/record.url?scp=84982843273&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84982843273&partnerID=8YFLogxK

U2 - 10.1016/j.snb.2016.05.163

DO - 10.1016/j.snb.2016.05.163

M3 - Article

AN - SCOPUS:84982843273

VL - 238

SP - 1144

EP - 1150

JO - Sensors and Actuators, B: Chemical

JF - Sensors and Actuators, B: Chemical

SN - 0925-4005

ER -